Brief: Paxmedica Receives Letter From Nasdaq That Co Has Not Regained Compliance With Minimum Market Value Requirement
16/06/2023 21:56
June 16 (Reuters) - PaxMedica Inc PXMD.O :
* PAXMEDICA INC - ON JUNE 12, RECEIVED LETTER FROM NASDAQ
THAT CO
HAS NOT REGAINED COMPLIANCE WITH MINIMUM MARKET VALUE
REQUIREMENT
* PAXMEDICA INC - INTENDS TO REQUEST HEARING BEFORE NASDAQ
HEARINGS PANEL TO APPEAL STAFF'S DELISTING DETERMINATION
Source text for Eikon: ID:
Further company coverage: PXMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kuvatris Therapeutics
See all newsBrief: PaxMedica Responds To Emergency Request For IV Suramin And Commits To Provide Immediate Access To PAX-101
PaxMedica rises on Malawi's request for access to sleeping sickness drug
Brief: Paxmedica Receives Emergency Request For Iv Suramin From African Health Ministry For Use In Treating Fatal Sleeping Sickness
Brief: PaxMedica Achieves Key Milestone In The Development Of PAX-101 And Provides Update On Potential NDA Submission
Brief: Paxmedica Announces Pricing Of $7.0 Million Public Offering